Navigation Links
Talecris Biotherapeutics Announces First Quarter 2011 Results
Date:4/27/2011

 Operating margin was 23.1% in the 2011 first quarter compared to 20.9% in the 2010 first quarter, an increase of 220 basis points.

Net interest expense was $10.8 million in the 2011 first quarter compared to $11.3 million in the prior year period, a decrease of $0.5 million.  The first quarter of 2011 reflected an income tax provision of $27.7 million resulting in a 33.3% effective tax rate compared to $23.3 million for the first quarter of 2010 or a 33.9% effective tax rate.  

Net income was $55.5 million for the 2011 first quarter including an after-tax charge of $3.0 million primarily related to Grifols merger-related expenses.  This compares to $45.3 million in the first quarter of 2010.

Diluted earnings per share for the 2011 first quarter were $0.43 compared to $0.35 for the 2010 first quarter.  The 2011 period included an after-tax charge of $0.02 per share primarily related to costs associated with the Grifols acquisition. Total diluted shares outstanding were 129,882,182 for the 2011 first quarter and 128,183,189 for the 2010 first quarter.

The 2011 first quarter EBITDA was $104.0 million compared to $87.9 million in the 2010 first quarter.  Adjusted EBITDA was $110.1 million in the 2011 first quarter compared to adjusted EBITDA of $96.7 million in the 2010 first quarter.  Additional information regarding the computation of non-GAAP financial measures is included in Exhibit B.

Recent EventsTalecris achieved a number of financial and commercial milestones in the first quarter of 2011.  These include:

  • On March 4, 2011, Talecris and Grifols announced that the "outside date" under the definitive merger agreement for closing of their pending transaction was extended to June 30, 2011 (from March 6, 2011).  Grifols extended the financing and financing commitments from its lenders to June 30, 2011 as well;

  • On March 3, 2011, Talecris was granted orphan drug desig
    '/>"/>

  • SOURCE Talecris Biotherapeutics Holdings Corp.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
    2. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
    3. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
    4. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
    5. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
    6. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
    7. Talecris Added to NASDAQ Biotechnology Index
    8. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
    9. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
    10. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
    11. Talecris Biotherapeutics Announces Premerger HSR Filing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... Convey Computer , the leader in ... State University won first place in the 2014 ... the team’s solution achieved the highest overall performance in ... place finisher. , Experts from all segments of the ... challenge, using a variety of design tools, hardware and ...
    (Date:10/20/2014)... , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Horovitz , Ph.D., from its board of directors effective on ... August 2003, and served as its chairman from June 2006 ... the Nominating and Corporate Governance and Audit Committees of the ... than a decade of dedicated service to GenVec, and its ...
    (Date:10/20/2014)... 20, 2014 Local veterinary surgeon, Dr. ... investigational study of donor stem cells for dogs with ... therapy and has performed clinical stem cell therapy for ... to determine if a single injection of donor stem ... help reduce pain and inflammation in the treated joints. ...
    (Date:10/19/2014)... (PRWEB) October 19, 2014 The ... bromine market in Asia-Pacific with analysis and forecast ... the Asia Pacific Bromine Market report, to get ... also provides a glimpse of the segmentation in ... various tables and figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html ...
    Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
    ... Families Can Invest Simultaneously in Future Healthcare and ... Inc., one of the world,s largest and most ... stem cell innovation, recently,renewed their agreement as an ... college funding contributions in America. Since,2004, Cryo-Cell has ...
    ... Sheets: CGCP), a leading developer of surgical products,used in ... financial results for its third quarter ended September 30, ... the third quarter of 2008 totaled $2,618,000, a 25% ... The lower revenue in,the current year quarter is primarily ...
    ... (Nasdaq: MEMY ), today reported its financial ... "Our results reflect continued clinical progress on ... into innovative therapies,",stated Vaughn M. Kailian, President and ... agreement with Roche to enhance our,ongoing Phase 2 ...
    Cached Biology Technology:Cryo-Cell Renews Upromise Industry-Exclusive Agreement 2Cryo-Cell Renews Upromise Industry-Exclusive Agreement 3Cryo-Cell Renews Upromise Industry-Exclusive Agreement 4Cardiogenesis Reports Third Quarter 2008 Results 2Cardiogenesis Reports Third Quarter 2008 Results 3Cardiogenesis Reports Third Quarter 2008 Results 4Cardiogenesis Reports Third Quarter 2008 Results 5Cardiogenesis Reports Third Quarter 2008 Results 6Cardiogenesis Reports Third Quarter 2008 Results 7Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results 8
    (Date:10/14/2014)... discriminating thieves, prostate cancer tumors scavenge and hoard copper ... such avarice may be a fatal weakness. , ... kill prostate cancer cells by delivering a trove of ... diseased cells brimming with the mineral, leaving non-cancer cells ... already commercially available for other uses, could soon be ...
    (Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
    (Date:10/14/2014)... led by researchers at the University of Massachusetts ... Miller School of Medicine (UMMSM) have identified what ... (manic depressive) disorder, a breakthrough that could lead ... as well as depression and other related mood ... week in Nature Molecular Psychiatry , show ...
    Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
    ... fracture) in women is highly recognized by the public. Less appreciated ... two million males have been diagnosed with osteoporosis and another three ... are thought to be major factors behind bone fractures in both ... low levels of the testosterone are known to be at risk. ...
    ... HARBOR, N.Y. In 1911, the influential geneticist Charles ... his ideas of how genetics would improve society in the ... foundation for the widespread eugenics movement in the United States. ... the 20th century have long been rejected, many of the ...
    ... University of Minnesota School of Public Health researchers have ... are less likely to engage in healthy activities such ... meals. They also consumed larger quantities of sweetened beverages ... and read or studied less than teens without TVs ...
    Cached Biology News:Testosterone replacement theraphy beneficial in men 60 and older 2Testosterone replacement theraphy beneficial in men 60 and older 3Reflecting on the social implications of human genetics research -- past, present and future 2U of M research finds teens who have TV in their bedroom are less likely to engage in healthy habits 2
    Please email us with project details and we will respond within 24 hours to your query!...
    Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution....
    Request Info...
    Request Info...
    Biology Products: